Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.
dc.contributor.author | Eapen, Zubin J | |
dc.contributor.author | Hammill, Bradley G | |
dc.contributor.author | Setoguchi, Soko | |
dc.contributor.author | Schulman, Kevin A | |
dc.contributor.author | Peterson, Eric D | |
dc.contributor.author | Hernandez, Adrian F | |
dc.contributor.author | Curtis, Lesley H | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2017-07-06T15:59:02Z | |
dc.date.available | 2017-07-06T15:59:02Z | |
dc.date.issued | 2013-09-11 | |
dc.description.abstract | BACKGROUND: Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. METHODS AND RESULTS: We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap. CONCLUSIONS: Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure. | |
dc.identifier | ||
dc.identifier | jah3301 | |
dc.identifier.eissn | 2047-9980 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Ovid Technologies (Wolters Kluwer Health) | |
dc.relation.ispartof | J Am Heart Assoc | |
dc.relation.isversionof | 10.1161/JAHA.113.000242 | |
dc.subject | Medicare Part D | |
dc.subject | heart failure | |
dc.subject | outcome assessment (health care) | |
dc.subject | Aged, 80 and over | |
dc.subject | Drug Utilization | |
dc.subject | Female | |
dc.subject | Heart Failure | |
dc.subject | Humans | |
dc.subject | Male | |
dc.subject | Medicare Part D | |
dc.subject | Prescription Drugs | |
dc.subject | United States | |
dc.title | Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure. | |
dc.type | Journal article | |
duke.contributor.orcid | Hammill, Bradley G|0000-0002-0389-6434 | |
duke.contributor.orcid | Peterson, Eric D|0000-0002-5415-4721 | |
duke.contributor.orcid | Hernandez, Adrian F|0000-0003-3387-9616 | |
duke.contributor.orcid | Curtis, Lesley H|0000-0002-3286-9371 | |
pubs.author-url | ||
pubs.begin-page | e000242 | |
pubs.issue | 5 | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | Duke Cancer Institute | |
pubs.organisational-group | Duke Clinical Research Institute | |
pubs.organisational-group | Duke Science & Society | |
pubs.organisational-group | Faculty | |
pubs.organisational-group | Initiatives | |
pubs.organisational-group | Institutes and Centers | |
pubs.organisational-group | Institutes and Provost's Academic Units | |
pubs.organisational-group | Medicine | |
pubs.organisational-group | Medicine, Cardiology | |
pubs.organisational-group | Medicine, General Internal Medicine | |
pubs.organisational-group | School of Medicine | |
pubs.publication-status | Published online | |
pubs.volume | 2 |
Files
Original bundle
- Name:
- Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.pdf
- Size:
- 263.79 KB
- Format:
- Adobe Portable Document Format